New antiepileptic drugs. II. Clinical use

Journal of Korean Medical Science

Volumn 11, Issue 4, 1996, Pages 289-304

  Lee, Byung In ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; FELBAMATE; FRUCTOSE; GABAPENTIN; ISOXAZOLE DERIVATIVE; LAMOTRIGINE; OXCARBAZEPINE; PROPANEDIOL DERIVATIVE; TOPIRAMATE; TRIAZINE DERIVATIVE; VIGABATRIN; ZONISAMIDE;

CLINICAL TRIAL; FORECASTING; HUMAN; REVIEW;

ACETIC ACIDS; AMINES; ANTICONVULSANTS; CARBAMAZEPINE; CLINICAL TRIALS; CYCLOHEXANECARBOXYLIC ACIDS; FORECASTING; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; ISOXAZOLES; PROPYLENE GLYCOLS; TRIAZINES; VIGABATRIN;

EID: 0030202936     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1996.11.4.289     Document Type: Article

References (98)

1. Alving J. Case of severe acute intoxication with oxcarbazepine combined with lamotrigine. Epilepsia 1994 ; 35(suppl 7) : S72.
2. Anhut H, Ashman P, Feuerstein TJ, et al. Gabapentin(neurontin) as add-on therapy in patents with partial seizures : a double-blind, placebo-controlled study. Epilepsia 1994 ; 35 : 795-801.
3. Appelton R. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993 ; 43(suppl 5) : S21-3.
4. Ben-Menachem E. Potential antiepileptic drugs : topiramate. In : Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs, 4th ed. New York : Raven Press Ltd, 1995 ; 1063-70.
5. Bernardina BD, Fontana E, Vigevano F, et al. Efficacy and tolerability of vigabatrin in children with refractory partial seizures : a single-blind dose increasing study. Epilepsia 1995 ; 36 : 687-91.
6. Besag FMC, Subel B, Pool F, et al. Carbamazepine toxicity with lamotrigine : a pharmacokinetic or pharmacodynamic interaction ? Epilepsia 1994 ; 35(suppl 7) : S73.
7. Binnie CD, Debets RMC, Engelsman M, et al. Double-blind crossover trial of lamotrigine as add-on therapy in intractable epilepsy. Epilepsy Res 1989 ; 4 : 222-9.
8. Bourgeois BFD, Leppik IE, Sackellares JC, et al. Felbamate double blind efficacy trial following presurgical monitoring. Epilepsia 1991 ; 32(suppl 3) : S18.
9. Brode MJ. Lamotrigine versus other antiepileptic drugs ; a star rating system is bom. Epilepsia 1994 ; 35(suppl 5) : S41-6.
10. Brodie MJ, Richens A, UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lamotrigine versus carbamazepine : a double-blind comparative study in newly diagnosed epilepsy. Lancet 1995 ; 345 : 476-9.
11. Browne TR, Mattson RH, Penry JK, et al. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures : an updtae. Neurology 1991 ; 41 : 363-4.
12. Chiron C, Dulac O, Beaumont D, et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991 ; 6(suppl 2) : S52-9.
13. Dam M, Ekberg R, Loayning Y, et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989 ; 3 : 70-6.
14. Dam M, Østergaard LH. Other antiepileptic drug : Oxcarbazepine. In : Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York : Raven Press Ltd, 1995 : 987-95.
15. Danish Oxcarbazepine Study Group. Oxcarbazepine in patients hypersensitive to carbamazepine. Acta Neurol Scand 1984 ; 70 : 223.
16. Devinsky O, Kothari M, Rubin R, et al. Felbamate for absence seizures. Epilepsia 1992 ; 33(suppl 3) : S84.
17. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology 1992 ; 43 : 2501-7.
18. Dulac O, chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991 ; 6 : 30-7.
19. Faught RE, Sachdeo RC, Remier MP, et al. Felbamate monotherapy for partial onset seizures : an active-control trial. Neurology 1993 ; 43 : 688-92.
20. Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993 ; 328 : 29-33.
21. Fisher RS, Kurrigan JFIII. Toxicity. In : Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York : Raven Press Ltd, 1995 ; 931-40.
22. French JA, Mosier M, Walker S, et al. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Neurology 1996 ; 46 : 54-61.
23. Grant SM, Heel RC. Vigabatrin : a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991 ; 41 : 889-926.
24. Gram L, Klosterskov P, Dam M. γ-Vinyl GABA : a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol 1985 ; 17 : 262-6.
25. Graves NM, Ritter FJ, Wagner ML, et al. Effect of lamotrigine on carbamazepine epoxide concentrations. Epilepsia 1991 ; 32(suppl 3) : S13.
26. Henry TR, Leppik IE, Gumnit RJ, Jacobs M. Progressive myoclonus epilepsy treated with zonisamide. Neurology 1988 ; 38 : 928-31.
27. Henry TR, Sackellares JC. Zonisamide. In : Resor Jr. St, Kutt H, eds. The Medical Treatment of Epilepsy. New York : Dekker, 1991 ; 432-27.
28. Houtkooper MA, Lammertsma A, Meyer JWA, et al. Oxcarbazepine(GO 47680) : a possible alternative to carbamazepine? Epilepsia 1987 ; 28 : 693-8.
29. Hwang YM, Kim HK, Kang JK, Lee MC. Clinical efficacy of vigabatrin as add-on therapy to valproic acid in intractable partial seizures. J Korean Neurol Assoc 1994 ; 12 : 666-74.
30. Jawad S, Richens A, Goodwin G, Yuen AWC. Controlled trial of lamotrigine for refractory seizures. Epilepsia 1989 ; 30 : 356-63.
31. Kälviäinen R, Äaikiä M, Saukkonen AM, et al. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. Arch Neurol 1995 ; 52 : 989-96.
32. Lee BI, Huh K, Kim JS, et al. Open clinical trial of vigabatrin as add-on therapy in severely intractable partial seizures. J Korean Neurol Assoc 1993 ; 11 : 85-98.
33. Lee BI, Park SC, Park HK, et al. Lamotrigine add-on therapy in patients with complex partial seizures receiving carbamazepine monotherapy. Epilepsia 1995 ;(suppl 3) : S115.
34. Lee KS, Kim BS, Chung JB, et al. Efficacy and safety of vigabatrin in refractory epilepsy. J Korean Neurol Assoc 1993 ; 11 : 99-104.
35. Leppik IE, Dreifuss FE, Pledger GW, et al. Felbamate for partial seizures : results of a controlled clinical trial. Neurology 1991 ; 41 : 1785-89.
36. Leppik IE, Willmore LJ, Homan RW, et al. Efficacy and safety of zonisamide : results of a multicenter study. Epilepsy Res. 1993 ; 14 : 165-73.
37. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989 ; 27 : 109-12.
38. Loiseau P, Hardenberg J, Pestre M, et al. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug resistant epilepsy. Epilepsia 1986 ; 27 : 115-20.
39. Loiseau P, Yuen AWC, Duche B, et al. Randomized double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment resistant partial seizures. Epilepsy Res 1990 ; 7 : 136-45.
40. Luna D, Dulac O, Pajot N, Beaumont D. Vigabatrin in the treatment of childhood epilepsies : a single-blind placebo-controlled study. Epilepsia 1989 ; 30 : 430-7.
41. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993 ; 43 : 2284-91.
42. McGuire AM, Duncan JS, Trimble MR. Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy. Epilepsia 1992 ; 33 : 128-34.
43. McKee PJW, Blacklaw J, Friel E, et al. Adjuvant vigabatrin in refractory epilepsy : a ceiling to effective dosage in individual patients? Epilepsia 1993 ; 34 : 937-43.
44. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures : a multicenter, placebo-controlled, double-blind crossover trial. Eplepsia 1994 ; 35 : 113-21.
45. Mumford JP, Dam M. Meta-analysis of European placebo-controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989 ; 27 : 101-7.
46. Nielsen OA, Johannessen AC, Bardrum B. Oxcarbazepine-induced hyponatremia, a cross-sectional study. Epilepsy Res 1988 ; 2 : 269-71.
47. Oguni H, Hayashi K, Fukuyama Y, et al. Phase IIIstudy of a new-antiepileptic AD-810, zonisamide in childhood epilepsy. Jpn J Pediatr 1988 ; 41 : 439-50.
48. Ono T, Yagi K, Seino M. Clinical efficacy and safety of a new antiepileptic drug, zonisamide. A multi-institutional phase three study. Clin Psychiat 1988 ; 30 : 471-82.
49. Panayiotopoulous CP, Ferrie CD, Knolt C, Robinson RO. Interaction of Lamotrigine with sodium valproate. Lancet 1993 ; 341 : 445.
50. Park HK, Lee BI, Park SC, et al. Combination therapy of lamotrigine and vigabatrin in patients with intractable partial epilepsy. Epilepsia 1995 ; (suppl 3) : S110.
51. Pitkäinen A, Ylinen A, Matilainen R, et al. Long-term anti-epileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients : a 5-year follow-up study. Arch Neurol 1993 ; 50 : 24-9.
52. Ramsay RE. Advances in the pharmacotherapy of epilepsy. Epilepsia 1993 ; 34(suppl 5) : S9-16.
53. Ramsay RE. Clinical efficacy and safety of gabapentin. Neurology 1994 ; 44(suppl 5) : S23-30.
54. Reife RA. Topiramate-a novel antiepileptic agent. Internal report of RWJPRI, 1994.
55. Remy C, Favel P, Tell G, et al. Etude en double aveugle contre placebo en permutations croiséss du vigabatrin dans l'épilepsie de l'adulte résistant a la therapeutique. Boll Lega Ital Epil 1986 ; 54/55 : 241-3.
56. Richens A, Yuen AWC. Cverview of the clinical efficacy of lamotrigine. Epilepsia 1992 ; 32(suppl 2) : S13-6.
57. Rimmer EM, Richens A. Double-blind study of γ-Vinyl GABA in patients with refractory epilepsy. Lancet 1984 ; 1 : 189-90.
58. Ring HA, Trimble MR, Costa DC, et al. Effect of vigabatrin on striatal dopamine receptors : evidence in humans for interactions of GABA and dopamine systems. J Neurol Neurosurg Psychiatry 1992 ; 55 : 758-61.
59. Risner ME. Multicenter, double-blind, placebo-controlled add-on crossover study of lamotrigine in epileptic outpatients with partial seizures. Epilepsia 1990 ; 31 : 619-20.
60. Rothman DL, Petroff OAC, Behar KL, Mattson RH. Brain GABA levels fail to rise as vigabatrin dose is doubled. Epilepsia 1994 ; 35(suppl 8) : S143.
61. Sabers A, Gram L. Pharmacology of vigabatrin. Pharmacol Toxicol 1992 ; 70 : 237-43.
62. Sachdeo RC, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy : controlled trial in patients with partial onset seizures. Ann Neurol 1992 ; 32 : 386-92.
63. Sachdeo RC, Murphy JV, Kamin M. Felbamate in juvenile myoclonic epilespy. Epilepsia 1992 ; 33(suppl 3) : S118.
64. Sander JWA, Patsalos PN, Oxley JR, et al. Randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990 ; 6 : 221-6.
65. Sander JWA, Hart YM, Trimble MR, Shorvon SD. Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry 1991 ; 54 : 435-9.
66. Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatr 1993 ; 54 : 448-53.
67. Schapel GJ, Dollman W, Beran RG, Dunagan FM. No effect of lamotrigine on carbamazepine and carbamazepine-epoxide concentrations. Epilepsia 1991 ; 32(suppl 1) : S58.
68. Schlumberger E, Chavez F, Palacios L, et al. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994 ; 35 : 359-67.
69. Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy : a European double-blind trial. Epilepsy Res 1993a ; 15 : 67-73.
70. Schmidt D, Ried S, Rapp P. Add-on treatment with lamotrigine for intractable epilepsy : a placebo-controlled cross-over trial. Epilepsia 1993b ; 34(suppl 2) : S66.
71. Seino M, Miyazaki H, Ito T. Zonisamide. In : Pisani F, Perucca E, Avanzini G, Richens A, eds. New Antiepileptic Drugs (Epilepsy Res : suppl 3). New York : Elsevier, 1991 ; 169-74.
72. Seino M, Naruto S, Tsugutaka I, Miyazaki H. Other anti-epileptic drug : zonisamide, In : Levy RH, Mattson RH, Meldrum BS eds. Antiepileptic Drugs, 4th ed. New York : Raven Press Ltd, 1995 ; 1011-23.
73. Seino M, Okuma T, Miyasaka M, et al. Efficacy evaluation of AD-810(zonisamide) ; double-blind study comparing with carbamazepine. J Clin Exp Med 1988 ; 144 : 275-91.
74. Sivenius J, Kälviäinen R, Ylinen A, et al. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991 ; 32 : 539-42.
75. Sivenius MRJ, Ylinen A, Murros K, et al. Double-blind dose reduction study of vigabatrin in complex partial epilepsy. Epilepsia 1987 ; 28 : 688-92.
76. Smith D, Barker G, Davies G, et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993 ; 34 : 312-22.
77. Steiner TJ, Silviera C, Yuen AWC. Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed patients. Epilepsia 1994 ; 35(suppl 7) : S61.
78. Stolarek I, Blacklaw J, Thompson GG, Brodie MJ. Vigabatrin and lamotrigine in refractory epilepsy. J Neurol Neurosurg Psychiatry 1994 ; 57 : 921-24.
79. Tanganelli P, Regestra G. Vigabatrin versus carbamazepine in newly diagnosed epileptic patients. Epilepsia 1994 ; 35(suppl 7) : S64.
80. Tartara A, Manni R, Galimberti CA, et al. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 1992 ; 86 : 247-51.
81. Tartara A, Manni R, Galimberti CA, et al. Vigabatrin in the treatment of epilepsy : a double-blind placebo-controlled study. Epilepsia 1986 ; 27 : 717-723.
82. Tartara A, Manni R, Galimberti CA, et al. Vigabatrin in the treatment of epilepsy : a long-term follow-up study. J Neurol Neurosurg Psychiatry 1989 ; 52 : 467-71.
83. Tassinari CA, Michelucci R, Ambrosetto G, Salvi F. Double-blind study of vigabatrin in the treatment of drug resistant epilepsy. Arch Neurol 1987 ; 44 : 907-10.
84. Theodore WH, Jensen PK, Kwan RM. Felbamate : Clinical use. In : Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York : Raven Press Ltd, 1995 ; 817-22.
85. Theodore WH, Raubertas R, Porter RJ, et al. Felbamate : a clinical trial for complex partial seizures. Epilepsia 1991 ; 32 : 392-7.
86. Timmings PL, Richens A. Lamotrigine as add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol 1992 ; 32 : 305-7.
87. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990 ; 335 : 1114-7.
88. US Gabapentin Study Group No.5. Gabapentin as add-on therapy in refractory partial epilepsy : a double-blind, placebo-controlled, parallel group study. Neurology 1994 ; 43 : 2292-8.
89. Warner T, Patsalos PN, Prevett M, et al. Lamotrigine-induced carbamazepine toxicity : an interaction with carbamazepine-10-11-epoxide. Epilepsy Res 1992 ; 11 : 147-50.
90. Wilder BJ, Ramsay RE, Guterman A, et al. A double-blind multicenter Placebo-controlled study of the efficacy and safety of zonisamide in the treatment of complex partial seizures in medically refractory patients. Internal report of Dainippon Pharmaceutical Co. 1986.
91. Wilensky AJ, Temkin NR, Ojemann LM, et al. Gabapentin and carbamazepine as monotherapy and combined : A pilot study. Epilepsia 1992 ; 33(suppl 3) : S77.
92. Willmore LJ, Shu V, Wallin B, M88-194 Study Group. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizure. Neurology 1996 ; 46 : 49-53.
93. Wolff DL, Kerrick JM, Rarick J, et al. Postmarket felbamate use in the refractory epilepsy population. Epilepsia 1994 ; 23(suppl 8) : S32.
94. Wolf SM, Shinnar S, Kang H, et al. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1996 ; 36 : 1203-5.
95. Yagi K, Seino M. Methodological requirements for clinical trials in refractory epilepsies-our experience with zonisamide. Prog Neuropsychopharmacol Biol Psychiatry 1992 ; 16 : 79-85.
96. Yagi K, Seino M, Watanabe Y, Kudo T. Change of urine volume and urinary components in patients with epilepsy before and after zonisamide treatment. Internal report of Dainippon Pharmaceutical Co, 1992 .
97. Yamatogi Y, Ohtahara S. Current topics of treatment. In : Ohtahara S, Roger J, eds. Proceedings, of the international symposium, new trends in pediatric epileptology. Department of Child Neurology, Okayama Medical School, 1991 ; 136-48.
98. Yuen AWC. Safety issues. In : Richens A, ed. Clinical update on lamotrigine : a novel antiepileptic drug. Tunbridge Wells : Wells Medical Ltd, 1992 ; 69-75.